Nngwe
ENDING THE DIAGNOSTIC ODYSSEY FOR
RARE DISEASE PATIENTS
The Nngwe Project, also known as the ONE Project, is a groundbreaking initiative using genomics to provide answers for rare disease patients in South Africa. Many individuals with rare and undiagnosed conditions face years-long diagnostic journeys, often with no clear outcome. By leveraging multi-Omics data, bioinformatics, and clinical expertise, Nngwe aims to shorten this journey, improve patient care, and drive new discoveries in precision medicine.
Aligned with South Africa’s National Development Plan 2030 and global commitments to equitable healthcare, Nngwe is ensuring that no patient is left behind. Through this initiative, DIPLOMICS is not just sequencing DNA, it’s changing lives.
109
PARTICIPANTS ENROLLED IN THE CHM RARE DISEASE BIOBANK IN 2024
131+
PARTICIPANTS ENROLLED IN 2024
Diagnosing the Impossible: The Oosthuizen Family's Rare Disease Journey
For years, Quezette and Tian Oosthuizen searched for answers to their children’s unexplained health challenges. Misdiagnoses and uncertainty became their norm, until a breakthrough in genomics finally revealed the cause. Explore how cutting-edge sequencing, supported by DIPLOMICS through the Nngwe project, helped uncover the truth behind a rare condition affecting their family.
WHAT PEOPLE ARE SAYING
Rare patients deserve to have access to diagnostics as it shortens the journey to supportive treatments, patient group engagement.
Prof. Christian Hendriksz
Chief Community Impact Office
One day, one day, one day
Eminem
Rapper
Music Record Label
